TREATMENT OF MASTITIS IN COWS: AN OVERVIEW OF THE PHARMACEUTICAL MARKET FOR THE MOST COMMON INJECTABLE THERAPIES

Abstract

Background. Mastitis is one of the most common diseases of dairy cows and causes significant economic losses due to reduced productivity, deterioration in milk quality, and increased veterinary costs. Under current conditions, the analysis of the availability and structure of the market for injectable drugs used in mastitis therapy is of particular importance. Purpose. To analyze the range of injectable medicinal products available on the modern pharmaceutical market of Ukraine for the treatment of mastitis in cows, evaluate their availability and pricing policy, and determine the prospects for expanding production and developing new products. Materials and Methods. The assortment analysis was carried out using the data of the State Register of Medicinal Products of Ukraine as of January 2026, the Compendium reference source, information from open sources, and veterinary pharmacy networks. Statistical, logical, and graphical methods of analysis were used. Results. It was established that the Ukrainian market is dominated by injectable antibiotics based on enrofloxacin, amoxicillin, ceftiofur, oxytetracycline, and cloxacillin. Non-steroidal anti-inflammatory drugs and immunomodulators also occupy a significant market share. Domestic manufacturers provide more than half of the market supply, while mono-drugs remain the predominant product type. The most common packaging format is 100 ml vials. An insufficient representation of combined products and injectable sulfonamides was identified. Conclusions. The market of injectable drugs for the treatment of mastitis in Ukraine is characterized by the dominance of classical antibiotics, a stable presence of supportive agents, and promising prospects for the development of combined and prolonged-release formulations. The obtained results can be used to optimize veterinary support for dairy farms and to plan the production of new medicinal products.